Literature DB >> 6372681

Bactericidal activities of chloramphenicol and eleven other antibiotics against Salmonella spp.

S R Preblud, C J Gill, J M Campos.   

Abstract

The bactericidal activity of chloramphenicol against 27 strains of Salmonella typhi and 33 strains of S. enteritidis was compared with those of 11 other antibiotics. The geometric mean bactericidal concentrations of chloramphenicol against susceptible strains (36.10 and 43.13 micrograms/ml for S. typhi and S. enteritidis, respectively) far exceeded those of the other 11 antibiotics, with cephalothin having the next highest values (2.67 and 8.66 micrograms/ml) and moxalactam (0.09 and 0.28 micrograms/ml), cefotaxime (0.08 and 0.28 micrograms/ml), ceftriaxone (0.07 and 0.16 micrograms/ml), norfloxacin (0.06 and 0.10 micrograms/ml), and aztreonam (0.05 and 0.20 micrograms/ml) having the lowest values. The results for imipenem (0.24 and 0.81 micrograms/ml) and ceftazidime (0.22 and 0.75 micrograms/ml) were lower than those noted for trimethoprim-sulfamethoxazole (1.20 and 5.56 micrograms/ml), cefamandole (0.62 and 3.29 micrograms/ml), and ampicillin (0.55 and 2.78 micrograms/ml). The MBC of chloramphenicol for some isolates decreased with increased incubation times such that the proportion of susceptible isolates killed by chloramphenicol at concentrations within achievable levels in blood increased from 10% after 24 h to 26% after 48 h of incubation. Although the MBC of the other 11 antibiotics for some isolates were also lowered by prolonged incubation, all 24-h values were within achievable levels in blood. The data indicate that chloramphenicol is not uniformly bacteriostatic against S. typhi and S. enteritidis. The in vivo significance of demonstrating delayed killing by chloramphenicol is, however, uncertain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372681      PMCID: PMC185509          DOI: 10.1128/AAC.25.3.327

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Treatment of typhoid fever with antibiotics.

Authors:  T E WOODWARD; J E SMADEL; R T PARKER; C L WISSEMAN
Journal:  Ann N Y Acad Sci       Date:  1952-12-30       Impact factor: 5.691

2.  Salmonella meningitis. A report of three cases and review of the literature.

Authors:  S G Rabinowitz; N R MacLeod
Journal:  Am J Dis Child       Date:  1972-03

3.  In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.

Authors:  M Maduri Traczewski; D A Goldmann; P Murphy
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

4.  pH-dependent oxacillin tolerance of Staphylococcus aureus.

Authors:  J S Venglarcik; L L Blair; L M Dunkle
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

5.  Cefazolin in the treatment of acute enteric fever.

Authors:  M Uwaydah
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

6.  Susceptibility of salmonellae to cephalosporins and to nine other antimicrobial agents.

Authors:  R Adams; J D Nelson
Journal:  Appl Microbiol       Date:  1968-10

7.  Ampicillin-chloramphenicol interaction against enteric Gram-negative organisms.

Authors:  B I Asmar; A S Dajani
Journal:  Pediatr Infect Dis       Date:  1983 Jan-Feb

8.  Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection.

Authors:  P A Anton; J A Kemp; T Butler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

9.  Antimicrobial resistance and R factors in Salmonella isolated from humans and animals in Georgia and South Carolina.

Authors:  A F Saad; W E Farrar
Journal:  South Med J       Date:  1977-03       Impact factor: 0.954

10.  Chloramphenicol combined with ampicillin in treatment of typhoid.

Authors:  F De Ritis; G Giammanco; G Manzillo
Journal:  Br Med J       Date:  1972-10-07
View more
  5 in total

Review 1.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 2.  Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; D M Richards
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

Review 3.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

4.  Therapy of experimental meningitis due to Salmonella enteritidis.

Authors:  J P Bryan; W M Scheld
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 5.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.